Alnylam Pharmaceuticals
ALNY
#571
Rank
ยฃ31.16 B
Marketcap
ยฃ234.98
Share price
-1.80%
Change (1 day)
25.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company